David Coman - 28 Apr 2023 Form 4 Insider Report for Science 37 Holdings, Inc.

Role: Chief Executive Officer
Signature: /s/ Christine Pellizzari, Attorney-in-fact for David Coman
Issuer symbol: N/A
Transactions as of: 28 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 02 May 2023, 16:23:39 UTC
Previous filing: 16 Aug 2022
Next filing: 15 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SNCE	Common Stock	Award		+615,650	+85%		1,341,787	28 Apr 2023	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SNCE	Stock Option	Disposed to Issuer		-981,437	-100%		0	28 Apr 2023	Common Stock	981,437	$10.05	Direct	F1
transaction	SNCE	Stock Option	Disposed to Issuer		-557,692	-100%		0	28 Apr 2023	Common Stock	557,692	$11.47	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 981,437 shares of common stock of the issuer and in exchange issued to the reporting person 392,574 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F2	On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 557,692 shares of common stock of the issuer and in exchange issued to the reporting person 223,076 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F3	Includes 615,650 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment.